21 transactions in 3 companies, from January 8, 2025 to September 22, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Verve Therapeutics, Inc. | VERV | 19 | — | $41K |
| Maze Therapeutics, Inc. | MAZE | 1 | — | — |
| Relay Therapeutics, Inc. | RLAY | 1 | — | — |
21 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Maze Therapeutics, Inc. | MAZE | Sekar KathiresanDirDERIV | Sep 22 | AAward | 18,000 | $0.00 | —? | 18,000derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 526,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 431,988 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 75,105 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 500,203 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 167,425 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 138,995 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 99,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 120,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 150,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jul 25 | DReturned to issuer | 488,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEO | Jul 25 | UTender offer | 240,997 | — | — | 0 |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEO | Jul 25 | UTender offer | 110,997 | — | — | 0 |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEO | Jul 25 | UTender offer | 348,431 | — | — | 0 |
| Relay Therapeutics, Inc. | RLAY | Sekar KathiresanDirDERIV | Jun 6 | AAward | 136,681 | $0.00 | —? | 136,681derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Apr 1 | MPLANOption exercise | 33,000 | $0.00 | —? | 99,000derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEO | Apr 2 | SPLAN | 9,822 | $4.15 | $41K | 346,686 |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEO | Apr 1 | MPLANOption exercise | 33,000 | — | — | 356,508 |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jan 8 | AAward | 150,000 | $0.00 | —? | 150,000derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jan 8 | AAward | 120,000 | $0.00 | —? | 120,000derivatives |
| Verve Therapeutics, Inc. | VERV | Sekar KathiresanCEODERIV | Jan 8 | AAward | 488,000 | $0.00 | —? | 488,000derivatives |